{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:05:52Z","timestamp":1792191952885,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/md.0000000000002487","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T17:16:05Z","timestamp":1452705365000},"page":"e2487","source":"Crossref","is-referenced-by-count":42,"title":["Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers"],"prefix":"10.1097","volume":"95","author":[{"given":"Yi-Chun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Cheng","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Lin","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Lun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Chao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-66-20210826","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R2-66-20210826","doi-asserted-by":"crossref","first-page":"e0125180","DOI":"10.1371\/journal.pone.0125180","article-title":"Co-medication of statins with contraindicated drugs","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"R3-66-20210826","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-158-12-201306180-00004","article-title":"Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study","volume":"158","author":"Patel","year":"2013","journal-title":"Ann Intern Med"},{"key":"R4-66-20210826","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","article-title":"Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring","volume":"29","author":"Zhou","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R5-66-20210826","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2013.282426","article-title":"Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury","volume":"310","author":"Gandhi","year":"2013","journal-title":"JAMA"},{"key":"R6-66-20210826","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1503\/cmaj.140950","article-title":"Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4","volume":"187","author":"Li","year":"2015","journal-title":"CMAJ"},{"key":"R7-66-20210826","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bmj.330.7497.960","article-title":"Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding","volume":"330","author":"Mamdani","year":"2005","journal-title":"BMJ"},{"key":"R8-66-20210826","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition","volume":"38","author":"Dresser","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"R9-66-20210826","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jcpt.12163","article-title":"The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians","volume":"39","author":"Kerr","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"R10-66-20210826","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0009-9236(98)90067-4","article-title":"The interaction of diltiazem with lovastatin and pravastatin","volume":"64","author":"Azie","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R11-66-20210826","first-page":"386","article-title":"The influence of simvastatin at high dose and diltiazem on myocardium in rabbits, the biochemical study","volume":"63","author":"Jasinska","year":"2006","journal-title":"Acta Pol Pharm"},{"key":"R12-66-20210826","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lfs.2004.06.022","article-title":"Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension","volume":"76","author":"Watanabe","year":"2004","journal-title":"Life Sci"},{"key":"R13-66-20210826","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1248\/yakushi.121.761","article-title":"Simvastatin and atorvastatin enhance hypotensive effect of diltiazem in rats","volume":"121","author":"Marumo","year":"2001","journal-title":"Yakugaku Zasshi"},{"key":"R14-66-20210826","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1345\/aph.1A481","article-title":"Rhabdomyolysis with concurrent atorvastatin and diltiazem","volume":"36","author":"Lewin","year":"2002","journal-title":"Ann Pharmacother"},{"key":"R15-66-20210826","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/pds.3199","article-title":"Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network","volume":"21","author":"Rowan","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R16-66-20210826","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11096-012-9642-2","article-title":"Evaluation of drug-drug interaction screening software combined with pharmacist intervention","volume":"34","author":"Moura","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"R17-66-20210826","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00228-012-1338-y","article-title":"Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care","volume":"69","author":"Andersson","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R18-66-20210826","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/j.ajkd.2014.04.015","article-title":"Drug-drug interactions and acute kidney injury: caveat prescriptor","volume":"64","author":"Mendu","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R19-66-20210826","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.arcmed.2014.01.009","article-title":"Long-term outcomes of dialysis patients after coronary revascularization: a population-based cohort study in Taiwan","volume":"45","author":"Chou","year":"2014","journal-title":"Arch Med Res"},{"key":"R20-66-20210826","doi-asserted-by":"crossref","first-page":"e1334","DOI":"10.1097\/MD.0000000000001334","article-title":"A Taiwanese nationwide cohort study shows interferon-based therapy for chronic hepatitis C reduces the risk of chronic kidney disease","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R21-66-20210826","doi-asserted-by":"crossref","first-page":"e1362","DOI":"10.1097\/MD.0000000000001362","article-title":"Increased risk of end-stage renal disease (ESRD) requiring chronic dialysis is associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs): nationwide case-crossover study","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R22-66-20210826","doi-asserted-by":"crossref","first-page":"e1222","DOI":"10.1097\/MD.0000000000001222","article-title":"Acute anticholinesterase pesticide poisoning caused a long-term mortality increase: a nationwide population-based cohort study","volume":"94","author":"Huang","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R23-66-20210826","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-8587(15)00287-9","article-title":"Mortality and metformin use in patients with advanced chronic kidney disease \u2013 Authors\u2019 reply","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R24-66-20210826","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/ndt\/gfr464","article-title":"Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan","volume":"27","author":"Lin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R25-66-20210826","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/hepr.12190","article-title":"Impact of renal dysfunction in cirrhotic patients with bacterial infections other than spontaneous bacterial peritonitis","volume":"44","author":"Hung","year":"2014","journal-title":"Hepatol Res"},{"key":"R26-66-20210826","doi-asserted-by":"crossref","first-page":"e0121705","DOI":"10.1371\/journal.pone.0121705","article-title":"Increased risks of mortality and atherosclerotic complications in incident hemodialysis patients subsequently with bone fractures: a nationwide case-matched cohort study","volume":"10","author":"Kuo","year":"2015","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201601120-00066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T14:20:46Z","timestamp":1629987646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201601120-00066"}},"subtitle":["A Nationwide Population-Based Study"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002487","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}